Brief: Vista Pharma submits ANDA to FDA for cardiac drug
26/09/2017 08:58
Sept 26 (Reuters) - Vista Pharmaceuticals Ltd VIPH.BO :
* Submitted ANDA to U.S. FDA for co's cardiac drug
Source text: http://bit.ly/2hvfRWc
Further company coverage: VIPH.BO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Vista Pharmaceuticals
See all newsBrief: Vista Pharmaceuticals Enters Joint Venture With Pleiades Therapeutics
Brief: Vista Pharmaceuticals To Issue 48.9 Million Warrants At 12 Rupees Each
Brief: Vista Pharmaceuticals To Issue Upto 17.4 Million Shares At Rupees 12.96 Each On Preferential Basis
Brief: Vista Pharmaceuticals To Consider Proposal For Raising Funds By Way Of Issue Of Preferential Issue Of Shares
Brief: Vista Pharmaceuticals Names Dhananjaya Alli As Chairman